https://www.mdmag.com/conference-coverage/ats-2020/budesonide-lama-laba-reduces-annual-copd-exacerbation Budesonide Plus LAMA/LABA Significantly Reduces Annual COPD Exacerbation Twice-daily budesonide/glycopyrrolate/formoterol significantly lowered exacerbations in patients with moderate or severe chronic obstructive pulmonary disease (COPD) versus a pair of double therapy inhalers, according to new findings.